High prevalence of fatty acid synthase expression in colorectal cancers in middle eastern patients and its potential role as a therapeutic target
Centre for Regenerative Medicine
OBJECTIVES:Many human epithelial cancers, particularly those with a poor prognosis, express high levels of fatty acid synthase (FASN), a key metabolic enzyme linked to synthesis of membrane phospholipids in cancer cells. Overexpression of FASN is linked with activation of the phosphatidylinositol-3'-kinase (PI3 K)/AKT pathway. However, the role of FASN in colorectal cancer (CRC) has not been fully elucidated. We investigated the expression of FASN and determined its functional association with the PI3/AKT pathway in CRC. METHODS:Expression of FASN and its associated targets were studied by immunohistochemistry on 448 CRC tumors in a tissue microarray (TMA) format. Analysis of apoptosis and cell cycle was evaluated in vitro using CRC cell lines by flow cytometry and DNA fragmentation assays. Protein expression was determined by immunohistochemistry and western blotting. In vivo xenograft studies were performed using CRC cell lines and NUDE mice.
RESULTS:Correlation of FASN with various clinicopathological parameters on 448 CRC samples was assessed. Activated AKT was found in 294/409 (71.9%) of CRC and was associated with FASN overexpression. FASN expression was observed in 27.1% (109/403) of Middle Eastern CRC. Additionally, FASN expression was significantly more common in tumors characterized by microsatellite instability (MSI) than in those characterized by microsatellite stability (MSS) (PCONCLUSIONS:These data identify FASN as a potential biomarker and a novel therapeutic target in distinct molecular subtypes of CRC.
American Journal of Gastroenterology
Ashari, L. H.,
Al-Kuraya, K. S.
(2009). High prevalence of fatty acid synthase expression in colorectal cancers in middle eastern patients and its potential role as a therapeutic target. American Journal of Gastroenterology, 104(7), 1790-1801.
Available at: https://ecommons.aku.edu/crm/53